Global Oligosaccharides in Infant Nutrition Market Segmentation, By Type (Galactoligosaccharides, Human Milk Oligosaccharides, and Fructooligosaccharides), Application (Food, Health Products, Drinks, Medicine, and Others) – Industry Trends and Forecast to 2031.
Oligosaccharides in Infant Nutrition Market Analysis
The oligosaccharides in infant nutrition market is experiencing significant growth, driven by increasing awareness of the health benefits associated with these bioactive compounds. Oligosaccharides, primarily found in human breast milk, are integral for infant gut health, immunity, and overall development. As breastfeeding rates vary globally and the need for high-quality infant formula rises, manufacturers are incorporating oligosaccharides to closely mimic the nutritional profile of human milk. Technological advancements in the production of oligosaccharides and supportive regulatory frameworks further bolster market growth.
Oligosaccharides in Infant Nutrition Market Size
Global oligosaccharides in infant nutrition market size was valued at USD 216.19 million in 2023 and is projected to reach USD 365.94 million by 2031, with a CAGR of 9.0% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Galactoligosaccharides, Human Milk Oligosaccharides, and Fructooligosaccharides), Application (Food, Health Products, Drinks, Medicine, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America
|
|
Market Players Covered
|
Abbott (U.S.), DuPont Nutrition & Health (U.S.), FrieslandCampina Domo (Netherlands), Ingredion (U.S.), Carbosynth (U.K.), Dairy Crest (U.K.), Inbiose (Belgium), Jennewein Biotechnologie (Germany), Tereos (France), ZuChem (U.S.), Elicityl (France), Dextra (U.K.)
|
|
Market Opportunities
|
|
Oligosaccharides in Infant Nutrition Market Definition
Oligosaccharides in infant nutrition refer to complex carbohydrates composed of short chains of sugar molecules, which are naturally found in human breast milk and are essential for the growth and development of infants. These bioactive compounds play a crucial role in promoting gut health by acting as prebiotics, stimulating the growth of beneficial gut bacteria. Oligosaccharides support the development of the immune system and may help protect against infections by preventing the adhesion of harmful pathogens to the gut lining.
Oligosaccharides in Infant Nutrition Market Dynamics
Drivers
- Growing Awareness of Infant Health
Parents today are more informed about the critical role of early nutrition in their children's development. They seek products that can offer the closest possible match to the benefits of natural breastfeeding. Oligosaccharides, known for their role in promoting gut health and boosting the immune system, are becoming a key ingredient in premium infant formulas. This growing awareness is pushing manufacturers to incorporate these beneficial compounds, thus expanding the market for oligosaccharides in infant nutrition. Increasing awareness among parents about the importance of infant health and nutrition is driving the demand for oligosaccharides in infant formulas.
- Rising Demand for Breastfeeding Alternatives
As breastfeeding rates fluctuate globally, there is a higher demand for infant formulas that closely replicate the benefits of human breast milk, including the addition of oligosaccharides. Many mothers are unable to breastfeed due to medical, personal, or professional reasons, leading them to seek alternatives that can provide similar nutritional benefits. Infant formulas enriched with oligosaccharides offer a solution by mimicking the prebiotic effects found in human milk, promoting better digestive health and immune function in infants. This increasing reliance on high-quality formula products is significantly driving the oligosaccharides market.
Opportunities
- Technological Advancements in Incorporation of Oligosaccharides
Innovations in the production and incorporation of oligosaccharides into infant nutrition products are enhancing their availability and effectiveness. Advances in biotechnology and food science have enabled the efficient extraction and synthesis of oligosaccharides, making them more accessible for use in infant formulas. These technological breakthroughs are not only improving the quality and efficacy of the products but also reducing production costs over time. This progress opens up new opportunities for manufacturers to develop and market a broader range of oligosaccharide-enriched infant nutrition products, creating new opportunities for growing consumer demand for advanced nutritional solutions.
- Increasing Disposable Incomes
Higher disposable incomes, particularly in emerging economies, are enabling consumers to spend more on premium infant nutrition products. As economies grow and living standards rise, parents in these regions are more willing and able to invest in high-quality nutrition for their infants. This trend is driving the demand for specialized and enriched formulas, including those containing oligosaccharides. The increasing purchasing power allows more consumers to opt for products that offer superior health benefits, thereby creating new opportunities for the market for oligosaccharides in infant nutrition.
Restraints/Challenges
- High Production Costs
The complex process of producing oligosaccharides can be expensive, potentially limiting their affordability and widespread use in infant nutrition. The production of oligosaccharides involves advanced biotechnological processes and stringent quality control measures, which contribute to high manufacturing costs. These expenses are often passed on to consumers, making oligosaccharide-enriched formulas more costly than standard options. This cost barrier can limit market growth, especially in price-sensitive regions where consumers may opt for more affordable alternatives.
- Limited Awareness in Developing Regions
In some developing regions, there is still limited awareness about the benefits of oligosaccharides in infant nutrition, which can slow market penetration. Despite the known health advantages, many parents and healthcare providers in these areas are not fully informed about the role of oligosaccharides in promoting gut health and boosting immunity. This lack of knowledge can hinder the adoption of oligosaccharides in nutrition.
Top of Form
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.
Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
Expected Impact of Economic Slowdown on the Pricing and Availability of Products
When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.
Latest Developments in Oligosaccharides in Infant Nutrition Market
- In November 2023, Nestlé announced the launch of its science-based growing-up milk solution featuring Human Milk Oligosaccharides (HMOs) for early life nutrition in mainland China, under the Wyeth illuma brand. This launch follows the recent approval by the National Health Commission of China for the use of these bioactive ingredients
- In November 2020, Abbott introduced its most innovative infant formula to date, Similac Pro-Advancewith 2'-Fucosyllactose Oligosaccharide (2'-FL), marking the first product in Canada to feature this ground breaking ingredient in infant formula
Oligosaccharides in Infant Nutrition Market Scope
The market is segmented on the basis of type and application. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Galactoligosaccharides
- Human Milk Oligosaccharides
- Fructooligosaccharides
Application
- Food
- Health Products
- Drinks
- Medicine
- Others
Oligosaccharides in Infant Nutrition Market Regional Analysis
The market is analyzed and market size insights and trends are provided by country, type, and application as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America is expected to dominate the market due to the rising disposable income of the population in countries such as China, India, and Japan. As economic conditions improve, more parents in these regions can afford premium infant nutrition products, including those enriched with oligosaccharides.
Asia-Pacific is expected to show significant growth due to the rising demand for innovative and high-quality nutritional products, including occasional calorie sweeteners used in the production of food and confectionery items. The region's well-established healthcare infrastructure, high consumer awareness, and strong market presence of leading infant nutrition companies contribute to this trend.
The country section of the report also provides individual market-impacting factors and changes in market regulation that affect the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Oligosaccharides in Infant Nutrition Market Share
The market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the market.
Some of the major market players operating in the market are:
- Abbott (U.S.)
- DuPont Nutrition & Health (U.S.)
- FrieslandCampina Domo (Netherlands)
- Ingredion (U.S.)
- Carbosynth (U.K.)
- Dairy Crest (U.K.)
- Inbiose (Belgium)
- Jennewein Biotechnologie (Germany)
- Tereos (France)
- ZuChem (U.S.)
- Elicityl (France)
- Dextra (U.K.)
SKU-